Our focus is expanding affordable access to NARCAN® (naloxone HCl) Nasal Spray - the leading
community use naloxone - and progressing our pipeline of opioid overdose and addiction treatments.


Our Pipeline

Our development pipeline includes four product candidates for opioid overdose and one product candidate for treatment of opioid addiction. These timelines are subject to change due to regulatory, clinical and other considerations.

Product Candidate Addressing Anticipated Regulatory Filing
AP002 Opioid overdose 2018
AP004 Opioid overdose 2018
AP003 Opioid overdose 2019
AP005 Opioid overdose 2020
AP007 Treatment of opioid addiction TBD
Pre-clinical Stage